Jacob Safier - Apr 10, 2024 Form 4 Insider Report for Orgenesis Inc. (ORGS)

Role: 10%+ Owner
Signature: /s/ Jacob Safier
Stock symbol: ORGS
Transactions as of: Apr 10, 2024
Transactions value $: $624
Form type: 4
Date filed: 12/4/2024, 06:48 PM
Previous filing: Feb 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORGS	Common Stock	Purchase	$5.95K	+10K	+0.32%	$0.59	3.12M	Apr 10, 2024	By JSAF Holdings, LLC	F1, F2
transaction	ORGS	Common Stock	Sale	-$5.44K	-10K	-0.32%	$0.54	3.11M	Apr 10, 2024	By JSAF Holdings, LLC	F1, F2
transaction	ORGS	Common Stock	Purchase	$5.14K	+10K	+0.32%	$0.51	3.12M	Apr 16, 2024	By JSAF Holdings, LLC	F1, F2
transaction	ORGS	Common Stock	Sale	-$5K	-10K	-0.32%	$0.50	3.11M	Apr 16, 2024	By JSAF Holdings, LLC	F1, F2
transaction	ORGS	Common Stock	Purchase	$5.8K	+10K	+0.32%	$0.58	3.12M	Jun 24, 2024	By JSAF Holdings, LLC	F1, F2
transaction	ORGS	Common Stock	Sale	-$5.81K	-10K	-0.32%	$0.58	3.11M	Jun 24, 2024	By JSAF Holdings, LLC	F1, F2
holding	ORGS	Common Stock						2M	Apr 10, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORGS	Warrant (right to buy)	Award	$0	+971K		$0.00	971K	Aug 21, 2024	Common Stock	971K	$1.03	Direct	F1, F3, F4
transaction	ORGS	Warrant (right to buy)	Award	$0	+243K		$0.00	243K	Sep 9, 2024	Common Stock	243K	$1.03	Direct	F1, F5, F6
transaction	ORGS	Warrant (right to buy)	Award	$0	+243K		$0.00	243K	Nov 4, 2024	Common Stock	243K	$1.03	Direct	F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jacob Safier is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	On September 25, 2024, the Issuer effected a reverse stock split at a ratio of 1-for-10. The share amounts set forth here are presented before giving effect to the reverse stock split.
F2	The Reporting Person is the portfolio manager of the investment in the Issuer by JSAF Holdings, LLC ("JSAF") and may therefore be deemed to beneficially own the shares owned by JSAF. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3	Pursuant to an Amended and Restated Promissory Note, dated as of August 10, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 1") exercisable for 970,873 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
F4	Other than 53,970 shares currently exercsiable, Warrant 1 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act"), more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
F5	Pursuant to an Amended and Restated Promissory Note, dated as of September 9, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 2") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
F6	Warrant 2 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
F7	Pursuant to an Amended and Restated Promissory Note, dated as of November 4, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 3") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
F8	Warrant 3 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.